Macrophage‐Tased Dual‐Phase T Cell Immunomodulation to Combat Transplant Rejection.
- Published in:
- Advanced Healthcare Materials, 2025, v. 14, n. 15, p. 1, doi. 10.1002/adhm.202403591
- By:
- Publication type:
- Article
Works by He, Mengrong
Results: 5
1
2
Orally Administrable Aggregation‐Induced Emission‐Based Bionic Probe for Imaging and Ameliorating Dextran Sulfate Sodium‐Induced Inflammatory Bowel Diseases (Adv. Healthcare Mater. 9/2023).
- Published in:
- Advanced Healthcare Materials, 2023, v. 12, n. 9, p. 1, doi. 10.1002/adhm.202370045
- By:
- Publication type:
- Article
3
Orally Administrable Aggregation‐Induced Emission‐Based Bionic Probe for Imaging and Ameliorating Dextran Sulfate Sodium‐Induced Inflammatory Bowel Diseases.
- Published in:
- Advanced Healthcare Materials, 2023, v. 12, n. 9, p. 1, doi. 10.1002/adhm.202202420
- By:
- Publication type:
- Article
4
Rapamycin Liposomes Targeted to Lymph Nodes Inhibit Dendritic Cell Maturation for the Treatment of Transplant Rejection.
- Published in:
- Particle & Particle Systems Characterization, 2024, v. 41, n. 11, p. 1, doi. 10.1002/ppsc.202400030
- By:
- Publication type:
- Article
5
Probiotic membrane vesicles ameliorate atherosclerotic plaques by promoting lipid efflux and polarization of foamy macrophages.
- Published in:
- Journal of Nanobiotechnology, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12951-025-03360-8
- By:
- Publication type:
- Article